ascopubs.org: Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
Patients with centrally located early-stage non–small-cell lung cancer (NSCLC) are at a higher risk of toxicity from high-dose ablative radiotherapy. NRG Oncology/RTOG 0813 was a phase I/II study ...
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
The Hill: The regulators’ new bank capital proposal ignores costs to consumers
The Federal Reserve, Federal Deposit Insurance Corporation and the Treasury Department issued a new proposal to force large banks to build up more capital through retained earnings and additional ...
The Hill: Tech safety groups slam House GOP proposal for 10-year ban on state AI regulation
A host of tech safety groups and at least one Democrat are blasting House Republicans’ proposal to block states from regulating artificial intelligence (AI) models for the next 10 years, arguing ...
Tech safety groups slam House GOP proposal for 10-year ban on state AI regulation
ascopubs.org: Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
EurekAlert!: NRG Oncology-RTOG 1308 accrual completion: First phase III NCTN clinical trial comparing photon versus proton therapy to meet accrual target
Effective , NRG Oncology-RTOG 1308, a phase III randomized trial comparing overall survival after photon versus proton chemoradiotherapy for patients with inoperable stage II-IIIB ...